SMC - September 2017 decisions

11 September 2017 - SMC accepts four new medicines for use by NHSScotland ...

Read more →

Blood cancer drug accepted for NHS use in Scotland

7 August 2017 - A drug which can increase survival rates for blood cell cancer sufferers has been accepted for ...

Read more →

SMC - August 2017 decisions

7 August 2017 - The Scottish Medicines Consortium has today published advice accepting three new medicines for routine use by ...

Read more →

Blood cancer treatment approved for use by NHS Scotland

10 July 2017 - Immunotherapy treatment nivolumab can now be used to treat Hodgkin lymphoma. ...

Read more →

New treatment for pulmonary arterial hypertension rejected for use on NHS

10 July 2017 - Patients living with pulmonary arterial hypertension have expressed disappointment at the Scottish Medicines Consortium's decision not ...

Read more →

New lung cancer drug approved for routine use in Scotland

10 July 2017 - A drug which could help advanced lung cancer sufferers has been approved for use on the ...

Read more →

SMC - July 2017 decisions

10 July 2017 - Medicines for lung cancer, lymphoma and Crohn’s disease accepted for routine use by NHSScotland. ...

Read more →

SMC industry engagement event

3 July 2017 - The SMC has announced details of the next Scottish Medicines Consortium Industry Engagement Event.  ...

Read more →

NHS Scotland reject ‘extremely effective’ breast cancer drug for third time despite drug being offered to English patients

12 June 2017 - The Scottish Medicines Consortium said that they don't believe Perjeta would be a 'good use of limited ...

Read more →

Two new kidney cancer drugs approved for NHS Scotland

12 June 2017 - Two new drugs for the treatment of incurable kidney cancer have been approved for use by ...

Read more →

SMC - June 2017 decisions

12 June 2017 - Four new medicines accepted for routine use by NHS Scotland. ...

Read more →

New guidance for patient group partners taking part in SMC Committee meetings

15 May 2017 - From June 2017, the SMC will be introducing new processes to improve how they involve patient ...

Read more →

Scottish Medicines Consortium approves Santhera's Raxone (idebenone) for restricted use in patients with LHON within NHS Scotland

9 May 2017 - Santhera Pharmaceuticals announces approval by the Scottish Medicines Consortium for restricted use of Raxone (idebenone) in ...

Read more →

SMC - May 2017 decisions

8 May 2017 - The Scottish Medicines Consortium has today published advice accepting three new medicines for routine use by ...

Read more →

Scotland gets life-extending ‘crucial’ cancer drug that is TOO EXPENSIVE for England

11 April 2017 - Scottish patients will be able to benefit from a breast cancer drug which could prolong life by ...

Read more →